These shares were acquired upon the exercise of stock options and subsequently sold pursuant to a 10b5-1 plan entered into between Greg Roth and Morgan Stanley Smith Barney dated May 10, 2012.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.74 to $46.31, inclusive. The reporting person undertakes to provide to Team Health Holdings, Inc., any security holder of Team Health Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The stock options are vested and exercisable with respect to 75% of the underlying shares and shall become exercisable with respect to the remaining 25% of the underlying shares on the fourth anniversary of the May 27, 2010 grant date.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Team Health Holdings makes a similar move, sign up!
Other recent filings from the company include the following: